{"id":"urine-sample","safety":{"commonSideEffects":[{"rate":null,"effect":"False positives"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The drug works by analyzing the chemical composition of urine to identify specific compounds. This is typically done through various chemical tests or immunoassays. The results are then used to diagnose or monitor various medical conditions.","oneSentence":"This drug is used to detect the presence of a substance in urine.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:53:11.019Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Detection of various substances in urine, including drugs of abuse, pregnancy, and certain medical conditions"}]},"trialDetails":[{"nctId":"NCT03816345","phase":"PHASE1","title":"Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-07-16","conditions":"Autoimmune Disease, Crohn Disease, Dermatomyositis","enrollment":300},{"nctId":"NCT07061964","phase":"PHASE2","title":"Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-11-25","conditions":"Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8","enrollment":111},{"nctId":"NCT04164082","phase":"PHASE2","title":"Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-03-18","conditions":"Bladder Flat Urothelial Carcinoma In Situ, Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8","enrollment":161},{"nctId":"NCT07495176","phase":"NA","title":"USC-Exos in Corpus Spongiosum Reconstruction for Hypospadias","status":"COMPLETED","sponsor":"Shanghai Children's Hospital","startDate":"2021-02-01","conditions":"Hypospadias","enrollment":82},{"nctId":"NCT04585958","phase":"PHASE1","title":"Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-05-21","conditions":"Metastatic Malignant Solid Neoplasm, Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma, Unresectable Malignant Solid Neoplasm","enrollment":55},{"nctId":"NCT07030166","phase":"","title":"A Machine Learning Prediction Model for Postoperative Acute Kidney Injury in Non-Cardiac Surgery Patients","status":"RECRUITING","sponsor":"Lanyue Zhu","startDate":"2025-07-01","conditions":"Kidney Injury, Acute","enrollment":10000},{"nctId":"NCT06982222","phase":"PHASE1","title":"Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-03-31","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Lung Non-Small Cell Carcinoma","enrollment":24},{"nctId":"NCT06169215","phase":"PHASE2","title":"Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-07-23","conditions":"Multiple Myeloma","enrollment":70},{"nctId":"NCT06172296","phase":"PHASE3","title":"Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-04-19","conditions":"Ganglioneuroblastoma, Nodular, Neuroblastoma","enrollment":478},{"nctId":"NCT03375320","phase":"PHASE3","title":"Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-10-26","conditions":"Functioning Pancreatic Neuroendocrine Tumor, Intermediate Grade Lung Neuroendocrine Neoplasm, Locally Advanced Digestive System Neuroendocrine Neoplasm","enrollment":298},{"nctId":"NCT07463807","phase":"PHASE1, PHASE2","title":"Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-06-26","conditions":"Recurrent Multiple Myeloma, Refractory Multiple Myeloma","enrollment":162},{"nctId":"NCT06695780","phase":"","title":"Food Typologies and Multidimensional Phenotyping of Elderly in Auvergne-Rhône-Alpes (Part'AGE)","status":"RECRUITING","sponsor":"Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement","startDate":"2025-02-03","conditions":"Nutritional Assessment, Physical Activity, Health","enrollment":1000},{"nctId":"NCT03606967","phase":"PHASE2","title":"Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-04-13","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma","enrollment":70},{"nctId":"NCT07369856","phase":"NA","title":"Spot Analysis of Natriuresis to Guide up- or Down-titration of Diuretic Therapy in Ambulatory Patients With Chronic Heart Failure","status":"RECRUITING","sponsor":"Cardiology Research UBC","startDate":"2025-11-04","conditions":"Heart Failure, Diuretics","enrollment":300},{"nctId":"NCT02965703","phase":"PHASE2","title":"Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-01-16","conditions":"Colorectal Adenoma, Colorectal Carcinoma","enrollment":81},{"nctId":"NCT07407569","phase":"PHASE2","title":"Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After HPV Vaccination","status":"RECRUITING","sponsor":"Universiteit Antwerpen","startDate":"2026-03-25","conditions":"Human Papilloma Virus Infection Type 16","enrollment":50},{"nctId":"NCT00086567","phase":"","title":"Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2005-12-12","conditions":"Fallopian Tube Cancer, Peritoneal Neoplasms, Epithelial Ovarian Cancer","enrollment":119},{"nctId":"NCT04181060","phase":"PHASE3","title":"Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-12-28","conditions":"Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma","enrollment":300},{"nctId":"NCT05658471","phase":"NA","title":"Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2023-02-01","conditions":"Nicotine Dependence, Tobacco Toxicity, Cardiovascular Risk Factors","enrollment":32},{"nctId":"NCT07198074","phase":"PHASE3","title":"Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-01-27","conditions":"Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma","enrollment":255},{"nctId":"NCT04579224","phase":"PHASE3","title":"Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-06-28","conditions":"Metastatic Bladder Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Refractory Bladder Urothelial Carcinoma","enrollment":184},{"nctId":"NCT06770582","phase":"PHASE2","title":"Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-06-03","conditions":"Non-Muscle Invasive Bladder Urothelial Carcinoma, Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage I Bladder Cancer AJCC v8","enrollment":160},{"nctId":"NCT06954987","phase":"PHASE2","title":"Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-07-17","conditions":"Acute Myeloid Leukemia","enrollment":244},{"nctId":"NCT05828069","phase":"PHASE2","title":"A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-03-28","conditions":"Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis","enrollment":48},{"nctId":"NCT06718894","phase":"NA","title":"Multitarget Strategy for Primary Podocytopathies","status":"RECRUITING","sponsor":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","startDate":"2025-06-19","conditions":"Nephrotic Syndrome","enrollment":150},{"nctId":"NCT06009926","phase":"PHASE2","title":"Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-12-04","conditions":"Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm, Occupational Malignant Neoplasm","enrollment":72},{"nctId":"NCT05564390","phase":"PHASE2","title":"MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-06-18","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy","enrollment":2000},{"nctId":"NCT06287775","phase":"PHASE1, PHASE2","title":"Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-04-08","conditions":"Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8","enrollment":45},{"nctId":"NCT07494981","phase":"","title":"Individualized Precision Therapy With Ceftazidime and Avibactam Guided by PK/PD in Geriatric Populations","status":"NOT_YET_RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2026-03-25","conditions":"Ceftazidime-avibactam","enrollment":150},{"nctId":"NCT03816319","phase":"PHASE1","title":"TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-03-12","conditions":"Myelodysplastic Syndrome With Excess Blasts, Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Syndrome","enrollment":42},{"nctId":"NCT07494864","phase":"","title":"Effects of Microbiological and Immunological Factors on the Lower Urinary Tract","status":"RECRUITING","sponsor":"University of Zurich","startDate":"2023-06-01","conditions":"Asymptomatic Bacteriuria in Subjects Not Requiring Assisted Bladder Emptying, Asymptomatic Bacteriuria in Subjects Relying on Some Type of Catheter, Recurrent Non-catheter Associated UTIs","enrollment":800},{"nctId":"NCT04167969","phase":"PHASE1","title":"The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-02-17","conditions":"Prostate Cancer","enrollment":16},{"nctId":"NCT03793166","phase":"PHASE3","title":"Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-06-07","conditions":"Clear Cell Renal Cell Carcinoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lymph Nodes","enrollment":1175},{"nctId":"NCT03712605","phase":"PHASE3","title":"Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-11-15","conditions":"Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8","enrollment":280},{"nctId":"NCT06948084","phase":"PHASE2","title":"Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-04-29","conditions":"Recurrent Multiple Myeloma, Refractory Multiple Myeloma","enrollment":80},{"nctId":"NCT06018831","phase":"NA","title":"Urine and Ultrasound Screening for Kidney Disease in Children","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2022-04-12","conditions":"Kidney Diseases, Diagnostic Techniques, Ultrasound","enrollment":13000},{"nctId":"NCT04071223","phase":"PHASE2","title":"Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-07-29","conditions":"Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma","enrollment":134},{"nctId":"NCT03866382","phase":"PHASE2","title":"Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-05-13","conditions":"Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, Bladder Mixed Adenocarcinoma","enrollment":314},{"nctId":"NCT00001309","phase":"PHASE1","title":"The Body's Affect on Vitamin C","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"1997-01-23","conditions":"Healthy Volunteers","enrollment":23},{"nctId":"NCT05256225","phase":"PHASE3","title":"Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-11-16","conditions":"Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma","enrollment":360},{"nctId":"NCT04847453","phase":"PHASE1","title":"Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-08-03","conditions":"Recurrent AL Amyloidosis, Refractory AL Amyloidosis","enrollment":24},{"nctId":"NCT05411081","phase":"PHASE2","title":"Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-03-24","conditions":"Metastatic Papillary Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8","enrollment":200},{"nctId":"NCT07340554","phase":"NA","title":"Neuroimaging of Adolescent Cannabis Use Treatment","status":"RECRUITING","sponsor":"Indiana University","startDate":"2026-04","conditions":"Cannabis Use, Cannabis Dependence, Cannabis Use Disorder","enrollment":80},{"nctId":"NCT05754892","phase":"NA","title":"Positioning of Molecular Markers in Clinical Routine for the Management of Patients With Adrenal Cancers/Tumors (COMETE-CARE)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-10-01","conditions":"Cancer, Adrenal","enrollment":450},{"nctId":"NCT05092958","phase":"PHASE3","title":"Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-06-03","conditions":"Advanced Bladder Urothelial Carcinoma, Advanced Renal Pelvis Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma","enrollment":654},{"nctId":"NCT04087798","phase":"NA","title":"Controlling Hypertension Through Education and Coaching in Kidney Disease","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2020-02-04","conditions":"Chronic Kidney Diseases, Chronic Disease, Chronic Kidney Disease, Stage 3 (Moderate)","enrollment":320},{"nctId":"NCT03228459","phase":"NA","title":"The ILERVAS Project: Assessing the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut de Recerca Biomèdica de Lleida","startDate":"2015-01-15","conditions":"Atherosclerosis, Chronic Kidney Diseases, Metabolic Syndrome","enrollment":16660},{"nctId":"NCT03017820","phase":"PHASE1","title":"A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2017-04-04","conditions":"B-Cell Non-Hodgkin Lymphoma, Histiocytic and Dendritic Cell Neoplasm, Myelodysplastic Syndrome","enrollment":127},{"nctId":"NCT06465316","phase":"PHASE1","title":"Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-12-06","conditions":"Recurrent Multiple Myeloma, Refractory Multiple Myeloma","enrollment":26},{"nctId":"NCT00083512","phase":"","title":"Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2004-06-22","conditions":"Glioblastoma Multiforme","enrollment":200},{"nctId":"NCT06771401","phase":"NA","title":"Identification of Biomarkers in Cervical Mucus","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2026-03-10","conditions":"Cervical Mucus Dysfunction, Infertility, Female","enrollment":24},{"nctId":"NCT07372547","phase":"NA","title":"Effect of Voiding Position (Standing in the Shower vs. Sitting) on Post-Void Residual Urine Volume (PVR) After Removal of Urinary Catheter in Women Following Benign Vaginal Gynecologic Surgery","status":"RECRUITING","sponsor":"Assuta Ashdod Hospital","startDate":"2026-01-20","conditions":"Post-void Residual Volume, Recatheterization, Pain","enrollment":100},{"nctId":"NCT02199145","phase":"NA","title":"Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2015-07-17","conditions":"Membranous Nephropathy","enrollment":52},{"nctId":"NCT07491042","phase":"NA","title":"Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients.","status":"RECRUITING","sponsor":"Oman Ministry of Health","startDate":"2026-04-01","conditions":"End Stage Chronic Renal Failure","enrollment":38},{"nctId":"NCT06593080","phase":"NA","title":"The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis","status":"RECRUITING","sponsor":"Chishala Chabala","startDate":"2024-06-01","conditions":"Tuberculosis, Child Health, HIV","enrollment":30240},{"nctId":"NCT00092235","phase":"","title":"Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2004-10-26","conditions":"Chronic Graft vs. Host Disease","enrollment":650},{"nctId":"NCT07484607","phase":"","title":"Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis","status":"RECRUITING","sponsor":"Alexander Horsley","startDate":"2025-10-09","conditions":"Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation","enrollment":200},{"nctId":"NCT00027326","phase":"","title":"Collection of Blood and Urine From Patients Undergoing Radiation Therapy","status":"ENROLLING_BY_INVITATION","sponsor":"National Cancer Institute (NCI)","startDate":"2001-12-02","conditions":"Carcinoma, Cancer, Tumor","enrollment":1000},{"nctId":"NCT04464434","phase":"PHASE4","title":"Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis","status":"COMPLETED","sponsor":"UMC Utrecht","startDate":"2020-09-17","conditions":"Systemic Sclerosis, Systemic Scleroses, Diffuse, Scleroderma","enrollment":60},{"nctId":"NCT06827054","phase":"PHASE2","title":"Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids","status":"NOT_YET_RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2026-05-15","conditions":"Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm","enrollment":20},{"nctId":"NCT06229990","phase":"PHASE4","title":"A Protocol Based-Furosemide Stress Test to Evaluate Renal Recovery During Continuous Renal Replacement Therapy","status":"RECRUITING","sponsor":"Chiang Mai University","startDate":"2024-01-01","conditions":"Acute Kidney Injury","enrollment":80},{"nctId":"NCT07049757","phase":"NA","title":"Healthy Family Project: Tobacco Use and Smoke Exposure in Asian American Communities","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-06-11","conditions":"Tobacco-Related Carcinoma, Smoking Cessation","enrollment":760},{"nctId":"NCT01087307","phase":"","title":"Sample Collection Registry for Quality Control of Biological and Environmental Specimens and Assay Development and Testing","status":"COMPLETED","sponsor":"National Institute of Environmental Health Sciences (NIEHS)","startDate":"2010-03-02","conditions":"Exposure","enrollment":5326},{"nctId":"NCT04529252","phase":"","title":"Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2017-07-17","conditions":"Spinocerebellar Ataxias, Cerebellar Ataxia, Nucleotide Repeat Disease","enrollment":1000},{"nctId":"NCT05727020","phase":"","title":"Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2022-12-15","conditions":"PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer","enrollment":1005},{"nctId":"NCT04476563","phase":"","title":"Checkpoint Inhibitor-induced Liver Injury","status":"RECRUITING","sponsor":"University of Nottingham","startDate":"2020-10-13","conditions":"Immune-Mediated Hepatitis","enrollment":160},{"nctId":"NCT04715464","phase":"","title":"Active Surveillance Cultures for Multidrug Resistant Gram-Negative Organisms at an Acute Care Hospital","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2015-02-12","conditions":"Infection","enrollment":2878},{"nctId":"NCT00090662","phase":"","title":"Collection of Data and Samples From Healthy Donors for Use in Translational Research","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2004-12-09","conditions":"Healthy Volunteer","enrollment":150},{"nctId":"NCT07131007","phase":"","title":"Construction and Evaluation of Tumor Immunotherapy and Organ Damage Early Warning System Based on Multi-omics","status":"RECRUITING","sponsor":"Hebei Medical University Fourth Hospital","startDate":"2025-09-15","conditions":"Malignant Neoplasm, Organ Damage","enrollment":2000},{"nctId":"NCT06694363","phase":"","title":"New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase δ Syndrome","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-06-26","conditions":"Activated PI3K Delta Syndrome","enrollment":14},{"nctId":"NCT05917522","phase":"PHASE2","title":"Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2023-12-07","conditions":"Kidney Transplant","enrollment":800},{"nctId":"NCT07487506","phase":"NA","title":"Evaluation and Assessment for Communicable Diseases in Migrants Hosted in Reception Centers","status":"RECRUITING","sponsor":"IRCCS Sacro Cuore Don Calabria di Negrar","startDate":"2025-04-08","conditions":"Infections","enrollment":250},{"nctId":"NCT01441687","phase":"NA","title":"Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Prediction of Prostate Cancer Biopsy Outcome","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2009-07-14","conditions":"Conditions Influencing Health Status, Healthy, Prostate Cancer","enrollment":243},{"nctId":"NCT07322406","phase":"NA","title":"Kaempferol Absorption and Pharmacokinetics Evaluation","status":"RECRUITING","sponsor":"University of Pittsburgh","startDate":"2025-12-09","conditions":"No Disease, Mitochondria Health, Longevity","enrollment":120},{"nctId":"NCT06810635","phase":"","title":"Polyphenol Metabotypes in People With Diabetes Type 2","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2026-03-04","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":100},{"nctId":"NCT05524311","phase":"PHASE2","title":"Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-11-10","conditions":"Juvenile Dermatomyositis","enrollment":16},{"nctId":"NCT04641351","phase":"PHASE4","title":"Corticosteroid Meniscectomy Randomized Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2021-05-27","conditions":"Osteoarthritis, Knee, Meniscus Tear, Meniscus; Degeneration","enrollment":150},{"nctId":"NCT07479095","phase":"NA","title":"Low-glucose/High-fat Intake Dietary Regimen as a Tool for Empowering Diagnostic Accuracy of 2-[18F]FDG PET/CT in Lepidic-predominant Growth Lung Adenocarcinoma","status":"RECRUITING","sponsor":"Fondazione del Piemonte per l'Oncologia","startDate":"2025-07-03","conditions":"Lepidic-Predominant Lung Adenocarcinoma, Lung Adenocarcinoma","enrollment":30},{"nctId":"NCT05279053","phase":"","title":"Mapping Brain Glutamate in Humans: Sex Differences in Cigarette Smokers","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2021-04-01","conditions":"Sex, Cigarette Smoking","enrollment":58},{"nctId":"NCT05268289","phase":"PHASE2","title":"Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-08-10","conditions":"Lupus Nephritis","enrollment":240},{"nctId":"NCT07485036","phase":"NA","title":"Maternal Outcomes: Mood, Alcohol Use, and Depressive Symptoms","status":"NOT_YET_RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2026-02-27","conditions":"Postpartum Depression (PPD), Alcohol Use, Contingency Management","enrollment":30},{"nctId":"NCT07483879","phase":"","title":"Biomarkers of Acute Organ Injury in Pediatric Newly Diagnosed Type 1 Diabetes","status":"RECRUITING","sponsor":"Aristotle University Of Thessaloniki","startDate":"2025-06-13","conditions":"Type 1 Diabetes Mellitus, Diabetic Ketoacidosis","enrollment":45},{"nctId":"NCT07017933","phase":"NA","title":"Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes","status":"RECRUITING","sponsor":"3ive Labs","startDate":"2025-07-16","conditions":"Renal Impairment After Cardiac Surgery, Renal Impairment, Acute Kidney Injury","enrollment":124},{"nctId":"NCT07482215","phase":"","title":"Prevalence and Molecular Identification of Human Schistosomiasis","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-05","conditions":"Schistosomiasis","enrollment":359},{"nctId":"NCT05202210","phase":"","title":"Constitution of a Biological Collection to Study the Pathophysiology in Noonan Syndrome","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2022-01-26","conditions":"Noonan Syndrome","enrollment":100},{"nctId":"NCT06054854","phase":"","title":"Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease)","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2024-06-13","conditions":"Lung Nodule, Lung Cancer","enrollment":3000},{"nctId":"NCT04751760","phase":"","title":"Feasibility Study of a New Immunoglobulin E (IgE) Assay Method","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2021-04-20","conditions":"Allergy and Immunology","enrollment":1376},{"nctId":"NCT06960902","phase":"NA","title":"Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2025-09-25","conditions":"Familial Hypercholesterolemias, Atherosclerotic Cardiovascular Disease (ASCVD)","enrollment":600},{"nctId":"NCT05373758","phase":"NA","title":"A Randomized Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Saharan Africa","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-02-07","conditions":"HIV Infections, AIDS, Virologic Failure","enrollment":648},{"nctId":"NCT07483151","phase":"","title":"Venous Congestion And Cognitive Dysfunction After Cardiac Surgery","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-11-01","conditions":"Intraoperative Venous Congestion And Cognitive Dysfunction After Cardiac Surgery","enrollment":110},{"nctId":"NCT07368712","phase":"NA","title":"A Methodological Study to Learn More About Kidney Function in Healthy People and in People With Reduced Kidney Function","status":"RECRUITING","sponsor":"Bayer","startDate":"2026-01-06","conditions":"Acute Kidney Injury, Renal Insufficiency","enrollment":50},{"nctId":"NCT06940531","phase":"","title":"Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis","status":"RECRUITING","sponsor":"Alexander Horsley","startDate":"2025-05-16","conditions":"Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation","enrollment":300},{"nctId":"NCT06516211","phase":"","title":"Predicate and Lay User-HCP Comparison Study of a Multi-Level Urine hCG Pregnancy Test","status":"NOT_YET_RECRUITING","sponsor":"Conceptra Biosciences, LLC","startDate":"2026-06-30","conditions":"Pregnancy","enrollment":180},{"nctId":"NCT07384325","phase":"NA","title":"Gravity in Flow: Automating Diuresis","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2025-06-02","conditions":"Automated Urine Monitoring, Urine Output, Fluid Balance","enrollment":75},{"nctId":"NCT06864494","phase":"","title":"Determination of Lipocalin Type-prostaglandin (L-PGDS) in Blood, Urine, Vaginal Samples and Endometrial Ablation by Enzyme-linked Immunosorbent Assay","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2025-06-25","conditions":"Adenomyosis, Endometriosis","enrollment":60},{"nctId":"NCT07479693","phase":"NA","title":"Comparison of Hyaluronic Acid, Injectable Platelet-Rich Fibrin, and Prolotherapy in TMJ Arthrocentesis","status":"COMPLETED","sponsor":"Ondokuz Mayıs University","startDate":"2025-01-01","conditions":"Temporomandibular Joint Pain, Arthrocentesis","enrollment":36},{"nctId":"NCT03078140","phase":"NA","title":"Iodine Supplement Strategies Between Routine Iodine Supplementation and Selective Iodine Supplementation","status":"COMPLETED","sponsor":"Chiang Mai University","startDate":"2017-05-01","conditions":"Pregnancy Related, Iodine Deficiency","enrollment":208},{"nctId":"NCT05374018","phase":"","title":"Urinary Antigen Test for Stretococcus Pneumoniae Serotype Prevalence in Community Acquired Pneumonia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2021-12-01","conditions":"Pneumonia","enrollment":1800},{"nctId":"NCT05223608","phase":"NA","title":"Prospective Cohort With Clinic-biologic Database of Patients Treated by Immunotherapy","status":"RECRUITING","sponsor":"Centre Oscar Lambret","startDate":"2022-03-03","conditions":"Solid Tumor, Adult","enrollment":500},{"nctId":"NCT07479134","phase":"NA","title":"Production of Stem Cells for the Generation of Pancreatic Cells","status":"RECRUITING","sponsor":"Ospedale San Raffaele","startDate":"2026-03-01","conditions":"Diabetes","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6640,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"urine sample","genericName":"urine sample","companyName":"University Hospital, Bordeaux","companyId":"university-hospital-bordeaux","modality":"Biologic","firstApprovalDate":"","aiSummary":"This drug is used to detect the presence of a substance in urine. Used for Detection of various substances in urine, including drugs of abuse, pregnancy, and certain medical conditions.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":7,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}